Health Economics from Theory to Practice by Simon Eckermann

Author:Simon Eckermann
Language: eng
Format: epub
Publisher: Springer International Publishing, Cham

6.5 Global Trials for Existing Technology

Robustly evaluating existing programs and technology would benefit from RCT evidence that cannot be feasibly or ethically collected within jurisdictions where it has already been adopted. Within jurisdictions where a strategy, therapy, program or existing technology has already been adopted, trialling will usually be infeasible and evaluation limited to observational evidence from practice – one arm or selected patients by arms. However, a global trial allows feasible trial recruitment in jurisdictions where the program or technology has not already been adopted and hence enables robust evidence of relative treatment effect. Consequently, societal decision maker global trials can also enable robust evaluation of existing programs as well as new technologies in jurisdictions who AT as part of a global trial, something we return to explore in greater detail in Chap. 11. The ability to robustly evaluate existing programs with global trials is suggested as particularly valuable in establishing optimal investment options with current technology and the health shadow price and opportunity cost of investing in new technology as explored in detail in Chap. 11, following Pekarsky (2012, 2015) and Eckermann and Pekarsky (2014).

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.